Angiotensin II Type 2 Receptor: A Novel Modulator of Inflammation in Pancreatic Ductal Adenocarcinoma through Regulation of NF-ΚB Activity
Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 5, Issue 1
Abstract
Aims: The aim of this study was to explore potential pro-inflammatory, pro-migratory and pro-invasive roles of angiotensin II type 2 receptor (AT2R) in pancreatic ductal adenocarcinoma (PDAC) cells. Study Design: AT2R-specific agonist (CGP42112A, CGP), blocking antibody, or siRNA were interchangeably used to analyze functional impact of AT2R on PDAC cell proliferation, migration, and invasion. Results: This study revealed that AT2R blockade reduced proliferation, migration and invasion of PDAC cells. Blocking AT2R significantly lowed the expression of oxidative-stress genes Nox1, Nox3, Nox4, and Nox5, and pro-invasive genes MMP-2, MMP-9, OPN, and α5-integrin. AT2R siRNA significantly downregulated the expression levels of pro-inflammatory IL-1beta, IFN-γ, iNOS, IL-6, IL-8, and IL-15 mRNA. Blocking AT2R also inhibited the intrinsic and angiotensin II (AngII) or CGP-mediated activation of NF-κB. Conclusion: These findings demonstrate previously unknown pro-inflammatory, pro-migratory and pro-invasive effects of AT2R in PDAC cells. Our data suggest that one mechanism by which AT2R promote inflammation is through activation of constitutive and AngII-mediated NF-κB. Thus, AT2R blockade could be a novel therapeutic strategy to target multiple pathways that mediate PDAC carcinogenesis.
Authors and Affiliations
Ankit V. Gandhi, Galina Chipitsyna, Daniel Relles, Charles J. Yeo, Hwyda A. Arafat
Keywords
Related Articles
- EP ID EP308889
- DOI 10.9734/JCTI/2017/31326
- Views 83
- Downloads 0
Symptoms Burden, Quality of Life and Its Determinant Factors in Advanced Lung Cancer Patients
Aims: To assess in advanced lung cancer patients’, reported symptoms burden, their QOL, and to identify determinant factors associated with their QOL in 2 healthcare departments. Study Design: A cross sectional study. Pl...
Granulocytic Sarcoma of Ovary Associated with Chronic Myelogenous Leukaemia Mimicking Carcinoma: A Rare Case Report
Granulocytic sarcoma is a rare haematological neoplasm due to extramedullary leukemic deposits. Granulocytic Sarcoma of ovary is even rare associated with chronic myeloid leukaemia and responds to imatinib treatment. A s...
Collision Tumor at the Gastroesophageal Junction; Coexistence of Basaloid Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma
Basaloid squamous cell carcinoma (BSC) is a poorly differentiated and rare variant of squamous cell carcinoma. It is frequently seen in the upper respiratory and gastrointestinal systems. Neuroendocrine tumors originate...
ABL1 is Overexpressed and Activated in Hepatocellular Carcinoma
Background and Aims: ABL1 is a non-receptor tyrosine kinase of the Abelson (Abl) family, which plays an important role in cell growth, survival, invasiveness, adhesion, and migration. Despite the well-known role of BCR-A...
Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patie...